BioSpace News Archive

Press Releases

Ocular Therapeutix™ to Report Second Quarter 2025 Financial Results on August 5, 2025

July 30, 2025
·
1 min read
Press Releases

MIRA Pharmaceuticals Announces FDA Clearance of IND for Ketamir-2, Enabling U.S. Clinical Trials in Neuropathic Pain

July 30, 2025
·
8 min read
Press Releases

Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease

July 30, 2025
·
11 min read
Press Releases

CytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business Highlights

July 30, 2025
·
7 min read
Press Releases

CDA Issues Positive Reimbursement Recommendation for SKYCLARYS™ (omaveloxolone), the Only Health Canada-Approved Treatment for Managing Friedreich Ataxia

July 30, 2025
·
4 min read
Press Releases

Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU

July 30, 2025
·
2 min read
Press Releases

Lilly’s Jaypirca (pirtobrutinib), the first and only approved non-covalent (reversible) BTK inhibitor, met its primary endpoint in a head-to-head Phase 3 trial versus Imbruvica (ibrutinib) in CLL/SLL

July 30, 2025
·
16 min read
Press Releases

NeoGenomics Reports Second Quarter 2025 Results

July 30, 2025
·
20 min read
Press Releases

Natera Announces Launch of ABCSG 61 (“TEODOR”), a Randomized Controlled Trial of Signatera™ in Early-Stage Breast Cancer

July 30, 2025
·
4 min read
Press Releases

Corning Announces Outstanding Second-Quarter 2025 Financial Results(1) Highlighted by Record Core Sales and Core EPS

July 30, 2025
·
13 min read